HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ECHA Releases Fourth Non-Animal Methods Report; ‘A Bricked-Up Window,’ Says PETA UK

Executive Summary

Animal-welfare groups have been critical of the European Chemicals Agency's administration of REACH's "last resort" principle. PETA UK says the agency's latest report to the European Commission on registrants' use of alternative, non-animal methods similarly comes up short.

You may also be interested in...



Endocrine Disruptors, The European Green Deal And The Politicization Of EU Chemical Programs

John Chave, director-general at Cosmetics Europe, says the European Commission’s plan for targeted assessment of 28 potential endocrine-disruptors in cosmetics – despite its conclusion in late 2018 that the current cosmetics regulatory framework adequately addresses endocrine-disruptor concerns – is symptomatic of a broad trend taking hold in Europe.

New EU REACH Nanomaterial Requirements Take Effect In 2020; Existing Dossiers Need Updates

Companies that manufacture or import nanoform substances subject to European REACH must meet new information requirements by 1 January 2020 under a regulation adopted by the Commission in late 2018. Final guidance from the European Chemicals Agency, currently available in draft form, is expected by year-end.

ECHA To Ramp Up REACH Compliance Checks, Targeting 30% Of All Registered Substances By 2027

Noncompliance with REACH information requirements remains an issue of concern for European authorities. ECHA aims to attack the problem by increasing the amount of compliance checks it performs while working with industry to drive improvements and national authorities to strengthen enforcement.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS150108

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel